Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
NF-κB inhibitor
DRUG CLASS:
NF-κB inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
SBI-756 (2)
BAY-61-3606 (1)
DC-1-192 (1)
EC-70124 (1)
sodium metaarsenite (1)
SBI-726 (1)
omtriptolide (1)
CBL0102 (1)
ascorbic acid/menadione (0)
Bay11-7082 (0)
CBL137 IV (0)
antroquinonol (0)
KLTi (0)
SR13668 (0)
efprezimod alfa (0)
bezisterim (0)
iMX-110 (0)
ETS2101 (0)
ACT001 (0)
PBI-05204 (0)
piceatannol (0)
SBI-756 (2)
BAY-61-3606 (1)
DC-1-192 (1)
EC-70124 (1)
sodium metaarsenite (1)
SBI-726 (1)
omtriptolide (1)
CBL0102 (1)
ascorbic acid/menadione (0)
Bay11-7082 (0)
CBL137 IV (0)
antroquinonol (0)
KLTi (0)
SR13668 (0)
efprezimod alfa (0)
bezisterim (0)
iMX-110 (0)
ETS2101 (0)
ACT001 (0)
PBI-05204 (0)
piceatannol (0)
›
Associations
(9)
News
Trials
VERI cancer hierarchy
Reset Filters
AKT1 overexpression
Glioblastoma
AKT1 overexpression
Glioblastoma
sodium metaarsenite
Sensitive: D – Preclinical
sodium metaarsenite
Sensitive
:
D
sodium metaarsenite
Sensitive: D – Preclinical
sodium metaarsenite
Sensitive
:
D
EGFR mutation
Non Small Cell Lung Cancer
EGFR mutation
Non Small Cell Lung Cancer
afatinib + omtriptolide
Sensitive: D – Preclinical
afatinib + omtriptolide
Sensitive
:
D
afatinib + omtriptolide
Sensitive: D – Preclinical
afatinib + omtriptolide
Sensitive
:
D
NRAS Q61K
Melanoma
NRAS Q61K
Melanoma
SBI-756
Sensitive: D – Preclinical
SBI-756
Sensitive
:
D
SBI-756
Sensitive: D – Preclinical
SBI-756
Sensitive
:
D
NRAS mutation
Melanoma
NRAS mutation
Melanoma
SBI-726
Sensitive: D – Preclinical
SBI-726
Sensitive
:
D
SBI-726
Sensitive: D – Preclinical
SBI-726
Sensitive
:
D
BIRC3 mutation
Chronic Lymphocytic Leukemia
BIRC3 mutation
Chronic Lymphocytic Leukemia
DC-1-192
Sensitive: D – Preclinical
DC-1-192
Sensitive
:
D
DC-1-192
Sensitive: D – Preclinical
DC-1-192
Sensitive
:
D
NF2 mutation
Mesothelioma
NF2 mutation
Mesothelioma
CBL0102
Sensitive: D – Preclinical
CBL0102
Sensitive
:
D
CBL0102
Sensitive: D – Preclinical
CBL0102
Sensitive
:
D
BCR-ABL1 fusion
B Acute Lymphoblastic Leukemia
BCR-ABL1 fusion
B Acute Lymphoblastic Leukemia
dasatinib + SBI-756
Sensitive: D – Preclinical
dasatinib + SBI-756
Sensitive
:
D
dasatinib + SBI-756
Sensitive: D – Preclinical
dasatinib + SBI-756
Sensitive
:
D
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
EC-70124
Sensitive: D – Preclinical
EC-70124
Sensitive
:
D
EC-70124
Sensitive: D – Preclinical
EC-70124
Sensitive
:
D
BBOX1 underexpression
Renal Cell Carcinoma
BBOX1 underexpression
Renal Cell Carcinoma
BAY-61-3606
Sensitive: D – Preclinical
BAY-61-3606
Sensitive
:
D
BAY-61-3606
Sensitive: D – Preclinical
BAY-61-3606
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login